Retatrutide Shows Multiple Metabolic Benefits in Diet‐Induced Obese <scp>MASH</scp> Mouse and Hamster Models
Retatrutide demonstrates multiple metabolic benefits in both mouse and hamster models. Our preclinical setting will help to assess the efficacy of novel therapies targeting obesity and MASH.
Authors
- NATALIA BREYNER
- E. Grasset (ORCID: https://orcid.org/0000-0002-3062-4733)
- Pierre Dillard (ORCID: https://orcid.org/0000-0002-4812-9159)
- Claire Bigot (ORCID: https://orcid.org/0009-0000-8291-1489)
- Camille Le Cudennec
- François Briand (ORCID: https://orcid.org/0000-0002-6771-6252)
- Thierry Sulpice
Institutions
- Janssen (France) (FR)
- Physiogenex (France) (FR)
Publication Details
- Journal
- Obesity
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1002/oby.70155
- Primary Topic
- Peroxisome Proliferator-Activated Receptors
- Type
- article
- Field-Weighted Citation Impact
- 0.00